TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 11.466
EU - Europa 4.213
AS - Asia 2.871
SA - Sud America 695
AF - Africa 92
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.341
Nazione #
US - Stati Uniti d'America 11.357
RU - Federazione Russa 1.365
IT - Italia 1.250
SG - Singapore 969
CN - Cina 790
BR - Brasile 592
IE - Irlanda 436
HK - Hong Kong 290
KR - Corea 280
DE - Germania 216
VN - Vietnam 211
GB - Regno Unito 187
SE - Svezia 144
FR - Francia 134
FI - Finlandia 130
IN - India 99
NL - Olanda 95
CA - Canada 62
ES - Italia 45
PL - Polonia 42
AT - Austria 38
ZA - Sudafrica 36
AR - Argentina 33
MX - Messico 33
BD - Bangladesh 32
UA - Ucraina 30
IQ - Iraq 25
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 23
EC - Ecuador 22
JP - Giappone 21
TR - Turchia 20
CO - Colombia 14
LT - Lituania 14
AE - Emirati Arabi Uniti 13
ID - Indonesia 13
BE - Belgio 12
EG - Egitto 12
IR - Iran 11
PE - Perù 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
JO - Giordania 8
BG - Bulgaria 7
CH - Svizzera 7
VE - Venezuela 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
PK - Pakistan 6
PY - Paraguay 6
AZ - Azerbaigian 5
GE - Georgia 5
LU - Lussemburgo 5
LV - Lettonia 5
MA - Marocco 5
AL - Albania 4
DK - Danimarca 4
HR - Croazia 4
KZ - Kazakistan 4
MY - Malesia 4
PH - Filippine 4
PT - Portogallo 4
AM - Armenia 3
BH - Bahrain 3
CR - Costa Rica 3
LB - Libano 3
LK - Sri Lanka 3
NG - Nigeria 3
YE - Yemen 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
NR - Nauru 1
PA - Panama 1
Totale 19.333
Città #
Dallas 9.439
Singapore 612
Moscow 453
Dublin 420
Hefei 327
Hong Kong 287
Seoul 279
Santa Clara 276
Ashburn 262
Milan 250
Siena 141
Florence 139
Beijing 138
Chandler 116
Los Angeles 90
Southend 87
Munich 86
Ho Chi Minh City 85
New York 68
Helsinki 67
Rome 60
São Paulo 58
Bengaluru 55
Fairfield 54
Chicago 53
Nuremberg 44
Princeton 43
The Dalles 38
Hanoi 37
Buffalo 36
Brescia 30
Lappeenranta 30
Shanghai 30
Turku 29
London 26
Abidjan 23
Lauterbourg 23
Rio de Janeiro 23
Seattle 23
Warsaw 23
Montreal 22
Redondo Beach 22
Johannesburg 21
Houston 20
Tokyo 20
Denver 19
Vienna 19
Portsmouth 18
Woodbridge 18
Boardman 17
Brasília 17
Gdynia 17
Stockholm 17
Düsseldorf 16
Orem 16
Wilmington 16
Council Bluffs 15
Curitiba 15
Málaga 15
Frankfurt am Main 14
Jacksonville 14
Washington 14
Boston 13
Brooklyn 13
Naples 13
Toronto 13
Brussels 12
Paris 12
Bologna 11
Brno 11
Figline Valdarno 11
Mexico City 11
Poplar 11
Atlanta 10
Belo Horizonte 10
Chennai 10
Comun Nuovo 10
Fremont 10
Messina 10
San Diego 10
Amsterdam 9
Baghdad 9
Cairo 9
Cambridge 9
Cape Town 9
Haiphong 9
Hải Dương 9
Lima 9
Querétaro 9
Salt Lake City 9
Tashkent 9
Tehran 9
Amman 8
Ankara 8
Charlotte 8
Guangzhou 8
Phoenix 8
San Francisco 8
Carrara 7
Catania 7
Totale 15.113
Nome #
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 7.193
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 604
A first update on mapping the human genetic architecture of COVID-19 542
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 463
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 331
An explainable model of host genetic interactions linked to COVID-19 severity 327
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 284
Pathogen-sugar interactions revealed by universal saturation transfer analysis 274
Mapping the human genetic architecture of COVID-19 269
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 266
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 258
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 258
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 241
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 236
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 228
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 206
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 198
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 198
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 187
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 169
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses 159
Colonizzazione da batteri multiresistenti nel trapianto di polmone ed eventi infettivi: studio pilota osservazionale-retrospettivo 158
ACKNOWLEDGEMENT OF REVIEWERS 156
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 148
Whole-genome sequencing reveals host factors underlying critical COVID-19 145
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 142
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: a retrospective observational multicenter study 139
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 138
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 138
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 134
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 132
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 132
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 131
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 130
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 126
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 125
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 124
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 120
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 118
PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests” 117
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 116
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 115
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 114
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 113
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study 113
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 111
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 108
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 107
Trattamento efficace di osteomielite sternale con raccolta purulenta da Klebsiella pneumoniae multiresistente in recente trapianto di polmone 103
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 103
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 101
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 99
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 98
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 98
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 96
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 96
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 96
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 96
Rapid Decrease in Fluoroquinolones Consumption following Implementation of a Simple Antimicrobial Stewardship Bundled Intervention in a University Hospital during the COVID-19 Pandemic 94
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 94
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 93
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 92
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 88
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 85
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 84
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 84
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 79
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 77
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 77
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 72
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment 71
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 71
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 68
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 68
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin? 67
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 66
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae 66
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 66
Use of colistin in adult patients: A cross-sectional study 64
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 63
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 60
Identification of two anti-Candida antibodies associated with the survival of patients with candidemia 58
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 58
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 56
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 56
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area 55
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 55
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study 54
SARS-CoV-2 infection in a highly experienced person living with HIV 54
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review 53
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients 47
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 29
Totale 19.651
Categoria #
all - tutte 50.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 7 1 10 5 4 5 3
2021/2022310 15 9 2 8 4 3 31 57 13 26 53 89
2022/2023773 38 82 91 65 36 109 98 85 56 34 59 20
2023/20241.021 48 34 101 65 52 197 292 53 10 40 43 86
2024/20253.486 149 98 250 144 452 204 337 203 244 206 344 855
2025/202613.886 568 3.313 7.173 1.228 1.372 232 0 0 0 0 0 0
Totale 19.651